Native Antigen Introduces Novel Coronavirus Antigens
The newly developed recombinant antigens derived specifically from COVID-19 are intended for use in infectious disease research, and assay and vaccine development.
Read MorePosted by | Feb 17, 2020 | Biochemicals & Chemical Reagents, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The newly developed recombinant antigens derived specifically from COVID-19 are intended for use in infectious disease research, and assay and vaccine development.
Read More